Complete Filing Data
Vaxcyte, Inc. reported Stockholders Equity of $2.69 billion for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Vaxcyte, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Net Income * | -$766.6M | -$463.9M | -$402.3M | -$223.5M | -$100.1M | -$89.2M | -$50.3M | -$29.5M |
| Research And Development Expense | $794.3M | $476.6M | $332.3M | $169.5M | $78.4M | $73.6M | $45.6M | $30.1M |
| Other Nonoperating Income Expense | $37.3M | -$4.4M | $2.9M | $8.8M | $3.6M | $364.0K | $3.9M | $6.0M |
| Operating Income Loss | -$923.7M | -$569.5M | -$468.0M | -$232.3M | -$103.7M | -$89.6M | -$54.2M | -$35.5M |
| Operating Expenses | $923.7M | $569.5M | $468.0M | $232.3M | $103.7M | $89.6M | $54.2M | $35.5M |
| General And Administrative Expense | $129.4M | $92.9M | $60.7M | $39.8M | $25.3M | $16.0M | $8.5M | $5.4M |
| Comprehensive Income Net Of Tax | -$761.2M | -$468.0M | -$401.7M | -$223.6M | -$100.3M | -$89.2M | -$50.3M | |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax | $9.5M | -$4.4M | $538.0K | -$120.0K | -$241.0K | |||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $538.0K | -$120.0K | -$241.0K | |||||
| Research And Development Expense To Related Party | $0.00 | $0.00 | $2.4M | $1.3M | $1.1M | $1.9M | ||
| Interest Expense | $0.00 | $2.0K | $7.0K | $7.0K | $40.0K | $75.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$212.8M | -$166.6M | -$140.7M | -$103.1M | -$128.7M | -$95.0M | -$92.7M | -$68.3M | -$60.5M | -$57.9M | -$48.5M | -$39.0M | -$26.6M | -$23.7M | -$21.2M | -$20.7M | -$21.0M | -$20.3M | -$27.1M | -$14.6M | -$11.3M | -$10.7M | -$13.7M |
| Research And Development Expense | $209.9M | $194.2M | $148.1M | $116.9M | $131.5M | $94.6M | $97.4M | $72.7M | $58.1M | $47.7M | $38.5M | $31.7M | $20.4M | $17.7M | $17.3M | $14.7M | $16.4M | $18.2M | $24.3M | $13.4M | $9.6M | $10.0M | $12.6M |
| Other Nonoperating Income Expense | $291.0K | $28.6M | $7.1M | $8.7M | $465.0K | -$2.2M | $20.4M | $18.8M | $10.7M | $660.0K | -$646.0K | $235.0K | $336.0K | $51.0K | $1.9M | -$1.3M | $290.0K | $904.0K | $454.0K | $1.2M | $823.0K | $1.6M | $273.0K |
| Operating Income Loss | -$242.4M | -$226.2M | -$180.8M | -$139.9M | -$153.0M | -$114.5M | -$113.0M | -$87.1M | -$71.2M | -$58.6M | -$47.9M | -$39.2M | -$27.0M | -$23.7M | -$23.1M | -$19.5M | -$21.3M | -$21.2M | -$27.6M | -$15.8M | -$12.1M | -$12.2M | -$13.9M |
| Operating Expenses | $242.4M | $226.2M | $180.8M | $139.9M | $153.0M | $114.5M | $113.0M | $87.1M | $71.2M | $58.6M | $47.9M | $39.2M | $27.0M | $23.7M | $23.1M | $19.5M | $21.3M | $21.2M | $27.6M | $15.8M | $12.1M | $12.2M | $13.9M |
| General And Administrative Expense | $32.4M | $32.0M | $32.7M | $23.0M | $21.5M | $19.9M | $15.6M | $14.5M | $13.1M | $10.9M | $9.4M | $7.5M | $6.5M | $6.1M | $5.9M | $4.8M | $4.9M | $3.0M | $3.3M | $2.5M | $2.5M | $2.3M | $1.3M |
| Comprehensive Income Net Of Tax | -$210.1M | -$168.1M | -$137.2M | -$104.8M | -$129.8M | -$92.3M | -$92.4M | -$70.9M | -$60.1M | -$57.7M | -$48.6M | -$39.6M | -$26.6M | -$23.6M | -$21.3M | -$21.0M | -$20.3M | -$27.1M | |||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax | $3.0M | $952.0K | $4.6M | $8.7M | -$445.0K | -$2.0M | $231.0K | -$2.6M | $408.0K | $247.0K | -$71.0K | -$592.0K | -$4.0K | $39.0K | -$47.0K | ||||||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $8.7M | -$445.0K | -$2.0M | $231.0K | -$2.6M | $408.0K | $247.0K | -$71.0K | -$592.0K | -$4.0K | $39.0K | -$47.0K | |||||||||||
| Research And Development Expense To Related Party | $0.00 | $0.00 | $0.00 | $0.00 | $747.0K | $1.6M | $143.0K | $98.0K | $218.0K | $1.0M | -$217.0K | ||||||||||||
| Interest Expense | $0.00 | $0.00 | $0.00 | $2.0K | $0.00 | $7.0K | $7.0K | $9.0K | $11.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $2.69B | $3.31B | $1.24B | $953.6M | $284.0M | $345.8M | -$106.4M | -$57.7M | -$29.1M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $175.4M | $389.2M | $398.6M | $835.5M | $69.9M | $386.2M | $59.0M | $66.1M | $36.1M |
| Cash And Cash Equivalents At Carrying Value | $174.0M | $387.9M | $397.5M | $834.7M | $69.0M | $386.2M | $59.0M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$213.8M | -$9.4M | -$437.0M | $765.7M | -$316.3M | $327.2M | -$7.1M | $30.0M | |
| Retained Earnings Accumulated Deficit | -$2.15B | -$1.39B | -$924.4M | -$522.1M | -$298.6M | -$198.6M | -$109.3M | ||
| Property Plant And Equipment Net | $257.4M | $198.0M | $79.6M | $10.4M | $8.0M | $3.3M | $3.4M | ||
| Prepaid Expense And Other Assets Current | $66.4M | $40.8M | $15.7M | $11.2M | $10.4M | $2.8M | $2.7M | ||
| Other Assets Noncurrent | $118.8M | $64.4M | $37.6M | $4.6M | $4.1M | $550.0K | $584.0K | ||
| Liabilities Current | $205.8M | $140.2M | $145.3M | $40.5M | $28.7M | $46.9M | $11.1M | ||
| Liabilities And Stockholders Equity | $3.00B | $3.51B | $1.41B | $1.01B | $324.3M | $392.8M | $65.7M | ||
| Liabilities | $317.2M | $205.5M | $167.4M | $52.6M | $40.3M | $47.0M | $11.8M | ||
| Employee Related Liabilities Current | $23.0M | $20.6M | $11.1M | $1.2M | $3.5M | $284.0K | $414.0K | ||
| Common Stock Value | $134.0K | $128.0K | $98.0K | $82.0K | $56.0K | $54.0K | $7.0K | ||
| Assets Current | $1.63B | $1.79B | $1.10B | $942.6M | $256.3M | $389.0M | $61.7M | ||
| Assets | $3.00B | $3.51B | $1.41B | $1.01B | $324.3M | $392.8M | $65.7M | ||
| Additional Paid In Capital Common Stock | $4.84B | $4.70B | $2.16B | $1.48B | $582.8M | $544.4M | $3.0M | ||
| Accrued Liabilities Current | $31.1M | $29.1M | $59.8M | $15.4M | $8.8M | $3.8M | $1.3M | ||
| Accounts Payable Current | $70.9M | $48.5M | $14.6M | $9.8M | $6.8M | $29.8M | $3.4M | ||
| Operating Lease Right Of Use Asset | $116.0M | $72.1M | $31.0M | $21.3M | $28.0M | $900.0K | |||
| Operating Lease Liability Current | $6.1M | $5.9M | $7.1M | $5.9M | $5.3M | $161.0K | |||
| Operating Lease Right Of Use Asset Amortization Expense | $8.5M | $8.8M | $7.0M | $6.6M | $1.7M | $0.00 | |||
| Assets Noncurrent | $1.38B | $1.72B | $312.0M | $63.6M | $68.0M | $3.8M | |||
| Accretion Amortization Of Discounts And Premiums Investments | $14.4M | $38.7M | $34.8M | $947.0K | -$1.4M | $0.00 | |||
| Operating Lease Liability Noncurrent | $111.4M | $65.2M | $22.1M | $12.0M | $11.5M | ||||
| Accrued Manufacturing Expenses | $74.7M | $36.2M | $8.3M | $4.4M | $13.0M | $5.8M | |||
| Short Term Investments | $1.39B | $1.36B | $682.8M | $96.7M | $177.0M | ||||
| Restricted Cash Noncurrent | $1.5M | $1.3M | $1.1M | $871.0K | $871.0K | ||||
| Long Term Investments | $881.7M | $1.39B | $162.7M | $26.5M | $27.1M | ||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $1.6M | -$3.9M | $179.0K | -$361.0K | -$241.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $2.89B | $3.07B | $3.20B | $3.42B | $1.99B | $1.98B | $1.40B | $1.43B | $944.8M | $359.3M | $366.5M | $359.5M | $306.0M | $317.0M | $326.9M | $364.1M | $383.2M | -$133.0M | -$92.2M | -$81.5M | -$71.1M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $282.5M | $308.1M | $348.2M | $1.05B | $519.8M | $612.6M | $546.2M | $531.9M | $381.3M | $279.3M | $239.0M | $202.6M | $112.9M | $151.9M | $199.8M | $397.0M | $410.0M | $154.8M | $33.3M | $42.5M | ||
| Cash And Cash Equivalents At Carrying Value | $281.1M | $306.7M | $346.9M | $1.05B | $518.7M | $611.5M | $545.1M | $531.0M | $380.5M | $278.4M | $238.2M | $201.7M | $112.0M | $151.0M | $198.9M | $397.0M | $410.0M | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$41.0M | $214.1M | -$454.2M | $132.8M | -$186.4M | $95.8M | ||||||||||||||||
| Retained Earnings Accumulated Deficit | -$1.91B | -$1.70B | -$1.53B | -$1.25B | -$1.15B | -$1.02B | -$743.6M | -$650.9M | -$582.6M | -$444.1M | -$386.2M | -$337.6M | -$270.1M | -$243.5M | -$219.8M | -$177.8M | -$156.8M | |||||
| Property Plant And Equipment Net | $253.5M | $242.3M | $217.2M | $163.2M | $126.0M | $84.8M | $11.4M | $16.4M | $15.2M | $9.9M | $10.2M | $10.1M | $6.6M | $5.7M | $5.0M | $2.5M | $2.8M | |||||
| Prepaid Expense And Other Assets Current | $55.8M | $54.3M | $44.8M | $33.4M | $28.8M | $30.6M | $29.8M | $23.3M | $18.6M | $7.5M | $9.2M | $7.6M | $24.4M | $9.4M | $3.6M | $3.8M | $3.0M | |||||
| Other Assets Noncurrent | $106.7M | $95.3M | $76.3M | $60.0M | $52.7M | $46.1M | $3.2M | $3.5M | $3.9M | $4.6M | $5.4M | $5.7M | $3.6M | $505.0K | $990.0K | $442.0K | $438.0K | |||||
| Liabilities Current | $200.0M | $154.5M | $97.0M | $123.8M | $82.8M | $87.1M | $85.6M | $60.2M | $52.7M | $39.3M | $30.5M | $27.2M | $47.5M | $40.7M | $55.0M | $39.6M | $32.9M | |||||
| Liabilities And Stockholders Equity | $3.17B | $3.31B | $3.38B | $3.56B | $2.09B | $2.09B | $1.50B | $1.50B | $1.01B | $412.1M | $411.6M | $402.7M | $354.1M | $358.1M | $382.4M | $403.8M | $416.2M | |||||
| Liabilities | $278.7M | $234.0M | $178.1M | $142.1M | $101.1M | $107.3M | $93.3M | $69.4M | $63.4M | $52.8M | $45.1M | $43.2M | $48.1M | $41.0M | $55.4M | $39.7M | $33.0M | |||||
| Employee Related Liabilities Current | $16.8M | $10.8M | $6.0M | $12.2M | $6.5M | $3.1M | $6.9M | $4.4M | $1.9M | $3.5M | $2.1M | $1.3M | $2.1M | $1.4M | $1.0M | $1.5M | $731.0K | |||||
| Common Stock Value | $133.0K | $133.0K | $132.0K | $127.0K | $114.0K | $112.0K | $98.0K | $97.0K | $84.0K | $64.0K | $62.0K | $59.0K | $56.0K | $55.0K | $54.0K | $54.0K | $54.0K | |||||
| Assets Current | $1.77B | $1.72B | $1.72B | $2.21B | $1.48B | $1.52B | $1.30B | $1.31B | $840.7M | $369.8M | $363.7M | $342.2M | $302.9M | $301.5M | $324.7M | $400.8M | $413.1M | |||||
| Assets | $3.17B | $3.31B | $3.38B | $3.56B | $2.09B | $2.09B | $1.50B | $1.50B | $1.01B | $412.1M | $411.6M | $402.7M | $354.1M | $358.1M | $382.4M | $403.8M | $416.2M | |||||
| Additional Paid In Capital Common Stock | $4.80B | $4.77B | $4.73B | $4.67B | $3.13B | $3.00B | $2.15B | $2.09B | $1.53B | $804.0M | $753.5M | $697.9M | $576.0M | $560.4M | $546.7M | $541.8M | $540.0M | |||||
| Accrued Liabilities Current | $24.6M | $32.2M | $26.0M | $30.8M | $22.2M | $54.2M | $15.0M | $19.2M | $18.4M | $13.7M | $9.9M | $7.7M | $12.0M | $7.5M | $5.8M | $2.9M | $3.3M | |||||
| Accounts Payable Current | $49.0M | $31.4M | $20.5M | $18.2M | $10.5M | $21.7M | $15.7M | $16.3M | $11.6M | $5.5M | $7.0M | $4.8M | $25.7M | $23.7M | $31.9M | $10.7M | $2.6M | |||||
| Operating Lease Right Of Use Asset | $83.5M | $85.6M | $87.8M | $28.7M | $26.8M | $28.9M | $16.3M | $18.0M | $19.7M | $22.9M | $24.6M | $26.1M | $307.0K | $654.0K | $1.0M | |||||||
| Operating Lease Liability Current | $5.8M | $6.3M | $6.1M | $9.6M | $7.3M | $7.2M | $6.0M | $6.0M | $5.9M | $6.4M | $6.6M | $6.6M | $613.0K | $710.0K | $833.0K | |||||||
| Operating Lease Right Of Use Asset Amortization Expense | $1.9M | $2.1M | $1.6M | $1.8M | $180.0K | |||||||||||||||||
| Assets Noncurrent | $1.40B | $1.59B | $1.66B | $1.35B | $605.8M | $574.2M | $200.6M | $192.5M | $167.5M | $42.3M | $47.9M | $60.5M | $51.1M | $56.5M | $57.6M | |||||||
| Accretion Amortization Of Discounts And Premiums Investments | $4.9M | $11.0M | $6.0M | -$321.0K | -$151.0K | |||||||||||||||||
| Operating Lease Liability Noncurrent | $78.7M | $79.5M | $81.1M | $18.3M | $18.3M | $20.2M | $7.8M | $9.2M | $10.6M | $13.4M | $14.6M | $15.8M | $553.0K | $225.0K | $295.0K | |||||||
| Accrued Manufacturing Expenses | $52.9M | $36.5M | $926.0K | $52.8M | $41.9M | $14.4M | $15.0M | $10.3M | $4.8M | $6.9M | $7.0M | $7.4M | $15.5M | $24.5M | $26.3M | |||||||
| Short Term Investments | $1.43B | $1.35B | $1.32B | $1.13B | $934.0M | $875.0M | $720.6M | $756.0M | $441.6M | $83.8M | $116.3M | $132.9M | $166.5M | $141.1M | $122.2M | |||||||
| Restricted Cash Noncurrent | $1.5M | $1.3M | $1.3M | $1.3M | $1.1M | $1.1M | $1.1M | $871.0K | $871.0K | $871.0K | $871.0K | $871.0K | $871.0K | $871.0K | $871.0K | |||||||
| Long Term Investments | $959.3M | $1.17B | $1.28B | $1.09B | $399.2M | $413.2M | $168.6M | $153.7M | $127.8M | $4.0M | $6.9M | $17.7M | $39.7M | $48.8M | $49.8M | |||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $856.0K | -$1.9M | -$322.0K | $139.0K | $1.8M | $2.9M | -$2.3M | -$2.5M | $47.0K | -$657.0K | -$904.0K | -$833.0K | -$12.0K | -$8.0K | -$47.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $138.8M | $84.8M | $48.8M | $23.7M | $10.7M | $5.4M | $1.2M | $749.0K |
| Payments To Acquire Property Plant And Equipment | $13.7M | $22.4M | $16.1M | $5.8M | $6.6M | $1.2M | $1.2M | $1.8M |
| Net Cash Provided By Used In Operating Activities | -$655.6M | -$452.6M | -$296.8M | -$170.6M | -$121.4M | -$46.6M | -$47.1M | -$30.5M |
| Net Cash Provided By Used In Investing Activities | $437.4M | -$2.01B | -$773.3M | $74.6M | -$212.3M | -$1.1M | -$1.2M | -$1.8M |
| Net Cash Provided By Used In Financing Activities | $2.0M | $2.45B | $639.8M | $861.5M | $17.8M | $374.9M | $41.6M | $62.2M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $16.8M | $5.8M | -$17.9M | -$433.0K | $7.4M | $58.0K | $1.1M | $378.0K |
| Increase Decrease In Other Operating Assets | $39.9M | $26.5M | $33.0M | $465.0K | $3.5M | $75.0K | -$120.0K | $412.0K |
| Increase Decrease In Accrued Liabilities | $6.0M | -$35.7M | $36.3M | $7.2M | $4.6M | $2.2M | $718.0K | $73.0K |
| Increase Decrease In Accrued Compensation | $2.3M | $9.5M | $9.9M | -$2.3M | $3.2M | -$130.0K | -$775.0K | $541.0K |
| Increase Decrease In Accounts Payable | $19.9M | $34.6M | $11.2M | $2.9M | -$12.5M | $26.1M | $868.0K | $1.3M |
| Depreciation Depletion And Amortization | $16.4M | $7.0M | $3.2M | $2.8M | $1.8M | $1.4M | $1.2M | $1.0M |
| Increase Decrease In Accrued Manufacturing Expenses | $31.1M | -$22.9M | $44.5M | $3.8M | -$8.6M | $7.2M | $4.0M | $1.6M |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $2.4M | $426.0K | -$6.7M | $137.0K | -$439.0K | $87.0K | -$341.0K | |
| Proceeds From Stock Options Exercised | $5.6M | $4.9M | $3.0M | $635.0K | $322.0K | $5.0K | ||
| Payments To Acquire Available For Sale Securities Debt | $1.21B | $3.09B | $1.33B | $102.7M | $336.3M | $0.00 | ||
| Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | $1.53B | $1.13B | $611.9M | $168.7M | $100.5M | $0.00 | ||
| Proceeds From Sale Of Available For Sale Securities Debt | $174.7M | $67.0M | $12.6M | $14.5M | $30.1M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|---|---|
| Share Based Compensation | $30.6M | $17.6M | $9.6M | $4.1M | $1.9M | $372.0K |
| Payments To Acquire Property Plant And Equipment | $5.4M | $5.7M | $5.6M | $2.9M | $1.2M | $349.0K |
| Net Cash Provided By Used In Operating Activities | -$166.3M | -$159.1M | -$47.7M | -$27.7M | -$13.2M | -$13.6M |
| Net Cash Provided By Used In Investing Activities | $123.3M | -$451.1M | -$448.1M | $49.7M | -$173.4M | -$349.0K |
| Net Cash Provided By Used In Financing Activities | $759.0K | $818.2M | $41.6M | $111.0M | $487.0K | $109.8M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $1.5M | $5.0M | $4.7M | -$2.8M | $557.0K | $951.0K |
| Increase Decrease In Other Operating Assets | $6.6M | $8.6M | -$615.0K | $1.6M | $441.0K | $89.0K |
| Increase Decrease In Accrued Liabilities | -$4.4M | -$4.4M | $3.0M | -$737.0K | $1.1M | $1.2M |
| Increase Decrease In Accrued Compensation | -$14.4M | -$8.0M | $699.0K | -$2.2M | $723.0K | -$65.0K |
| Increase Decrease In Accounts Payable | -$29.2M | $5.7M | $1.8M | -$1.9M | $2.2M | -$723.0K |
| Depreciation Depletion And Amortization | $3.0M | $999.0K | $712.0K | $582.0K | $347.0K | $384.0K |
| Increase Decrease In Accrued Manufacturing Expenses | -$51.8M | $6.7M | $2.4M | $2.5M | $13.2M | |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $1.2M | $6.1M | $23.0K | -$227.0K | -$281.0K | |
| Proceeds From Stock Options Exercised | $6.0M | $5.0M | $502.0K | $282.0K | $487.0K | $49.0K |
| Payments To Acquire Available For Sale Securities Debt | $314.5M | $687.7M | $483.8M | $7.0M | $172.1M | |
| Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | $438.5M | $242.3M | $40.2M | $59.6M | ||
| Proceeds From Sale Of Available For Sale Securities Debt | $26.1M | $6.4M | $1.1M | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$5.63 | -$3.80 | -$4.14 | -$3.44 | -$1.93 | -$3.02 | -$13.25 | -$8.12 |
| Weighted Average Number Of Shares Outstanding Basic | 136.1M | 122.0M | 97.2M | 64.9M | 51.9M | 29.5M | ||
| Weighted Average Number Of Diluted Shares Outstanding | 136.1M | 122.0M | 97.2M | 64.9M | 51.9M | 29.5M | ||
| Earnings Per Share Basic | $-5.63 | $-3.80 | $-4.14 | $-3.44 | $-1.93 | $-3.02 | ||
| Common Stock Shares Outstanding | 131.1M | 124.9M | 95.4M | 79.5M | 53.0M | 51.1M | 4.1M | |
| Common Stock Shares Issued | 131.1M | 124.9M | 95.4M | 79.5M | 53.0M | 51.1M | 4.1M | |
| Common Stock Shares Authorized | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 52.0M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 0.00 | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 51.9M | 29.5M | 3.8M | 3.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.56 | -$1.22 | -$1.04 | -$0.83 | -$1.10 | -$0.85 | -$0.91 | -$0.70 | -$0.70 | -$0.93 | -$0.80 | -$0.68 | -$0.51 | -$0.46 | -$0.41 | -$0.41 | -$0.41 | -$1.72 | -$6.70 | -$3.69 | -$2.93 | -$2.90 | -$3.72 |
| Weighted Average Number Of Shares Outstanding Basic | 136.2M | 136.0M | 135.7M | 123.7M | 117.3M | 111.7M | 101.7M | 98.1M | 86.2M | 62.0M | 60.8M | 57.5M | 52.2M | 51.5M | |||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 136.2M | 136.0M | 135.7M | 123.7M | 117.3M | 111.7M | 101.7M | 98.1M | 86.2M | 62.0M | 60.8M | 57.5M | 52.2M | 51.5M | |||||||||
| Earnings Per Share Basic | $-1.56 | $-1.22 | $-1.04 | $-0.83 | $-1.10 | $-0.85 | $-0.91 | $-0.70 | $-0.70 | $-0.93 | $-0.80 | $-0.68 | $-0.51 | $-0.46 | |||||||||
| Common Stock Shares Outstanding | 130.0M | 129.8M | 128.9M | 124.4M | 110.6M | 108.8M | 95.1M | 93.8M | 80.6M | 60.6M | 58.6M | 56.5M | 52.6M | 52.0M | 51.3M | 50.9M | 50.9M | ||||||
| Common Stock Shares Issued | 130.0M | 129.8M | 128.9M | 124.4M | 110.6M | 108.8M | 95.1M | 93.8M | 80.6M | 60.6M | 58.6M | 56.5M | 52.6M | 52.0M | 51.3M | 50.9M | 50.9M | ||||||
| Common Stock Shares Authorized | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 66.0M | ||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | |||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 57.5M | 52.2M | 51.5M | 51.2M | 51.0M | 50.9M | 11.8M | 4.0M | 4.0M | 3.9M | 3.7M | 3.7M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $138.8M | $84.8M | $48.8M | $23.7M | $10.7M | $5.4M | $1.2M | $749.0K |
| Investment Income Interest | $119.7M | $110.0M | $62.9M | $8.4M | $344.0K | $244.0K | $632.0K | $903.0K |
| Stock Issued During Period Value Stock Options Exercised | $5.6M | $4.9M | $3.0M | $635.0K | $322.0K | $5.0K | ||
| Adjustments To Additional Paid In Capital Vesting Of Early Exercised Stock Options | $8.0K | $8.0K | $16.0K | $164.0K | $122.0K | $133.0K | ||
| Foreign Currency Transaction Gain Loss Before Tax | -$1.9M | -$1.5M | $1.7M | -$2.4M | -$135.0K | $42.0K | ||
| Grant Income | $4.8M | $1.9M | $1.6M | $2.5M | $237.0K | |||
| Capital Expenditures Incurred But Not Yet Paid | $7.5M | $13.2M | $8.5M | $110.0K | $766.0K | $494.0K | $21.0K | $3.0K |
| Stock Issued During Period Value Employee Stock Purchase Plan | $13.0M | $27.1M | $7.7M | $5.9M | $888.0K | $374.0K | ||
| Release Of Restricted Stock Units Value | $3.9M | $861.0K | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $35.3M | $36.9M | $30.6M | $21.3M | $21.6M | $17.6M | $13.2M | $12.5M | $9.6M | $6.6M | $5.9M | $4.1M | $2.9M | $2.8M | $1.9M | $1.8M | $1.3M | $372.0K | $266.0K | $278.0K | $266.0K |
| Investment Income Interest | $29.3M | $31.1M | $32.9M | $28.1M | $23.8M | $21.7M | $18.5M | $16.5M | $10.4M | $1.2M | $399.0K | $134.0K | $90.0K | $93.0K | $61.0K | $33.0K | $44.0K | $135.0K | $120.0K | $181.0K | |
| Stock Issued During Period Value Stock Options Exercised | $11.7M | $2.7M | $5.0M | $2.2M | $884.0K | $502.0K | $1.8M | $324.0K | $282.0K | $491.0K | $466.0K | $487.0K | $108.0K | $297.0K | $49.0K | $314.0K | $2.0K | ||||
| Adjustments To Additional Paid In Capital Vesting Of Early Exercised Stock Options | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $9.0K | $9.0K | $12.0K | $128.0K | $55.0K | $20.0K | $20.0K | ||||||
| Foreign Currency Transaction Gain Loss Before Tax | $8.5M | $44.0K | -$2.4M | $227.0K | -$107.0K | -$317.0K | -$687.0K | -$1.7M | $6.0K | -$54.0K | -$414.0K | $1.9M | -$530.0K | -$176.0K | -$3.0K | -$186.0K | -$53.0K | ||||
| Grant Income | $292.0K | $394.0K | $126.0K | $1.6M | $2.5M | $654.0K | $157.0K | $690.0K | $160.0K | $299.0K | $378.0K | $787.0K | $1.0M | $329.0K | $54.0K | ||||||
| Capital Expenditures Incurred But Not Yet Paid | $3.9M | $13.7M | $57.0K | $664.0K | $1.5M | $35.0K | |||||||||||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $306.0K | $3.2M | $6.0M | $11.7M | $4.4M | $5.0M | $1.0M | $550.0K | $490.0K | ||||||||||||
| Release Of Restricted Stock Units Value | $9.3M | $565.0K | $3.3M | $2.6M | $214.0K | $727.0K | $861.0K | $0.00 |
Most recent annual filing with the SEC: February 24, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.